MedTrace Logo

Better Disease Control by Multidrug Regimen in Scabies

NCT05198947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2022-01-20

No results posted yet for this study

Summary

Scabies is associated with significant discomfort and social taboo. Existing treatment regimen frequently fails due to lack of patient compliance. We compared single use regimen to existing standard repeat application regimen for treatment of scabies.

Conditions

  • Scabies

Interventions

DRUG

Permethrin Lotion 5%

Topical permethrin 5% lotion to apply on day 1 and repeat after 1 week.

DRUG

Permethrin Lotion 5% and Oral Ivermectin 200 mcg/kg

Topical permethrin 5% lotion and oral ivermectin 200 mcg/kg to be taken on day 1 only.

Sponsors & Collaborators

  • B.P. Koirala Institute of Health Sciences

    lead OTHER

Principal Investigators

  • Prajwal Pandey, MD · B.P. Koirala Institute of Health Sciences

  • Sudha Agrawal, MD · B.P. Koirala Institute of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2018-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05198947 on ClinicalTrials.gov